Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
272 participants
OBSERVATIONAL
2020-05-31
2025-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In comparison with seizures, these cognitive disorders are a major additional factor in occupational, social and family disability. They are particularly frequent (50%) in temporal epilepsies and preferably concern memory and language skills.
The cognitive consequences of epilepsy are therefore well described in the following areas: episodic memory, language, executive functions.
Concerning attentional abilities, a recent review has highlighted the lack of work in this specific field in order to properly measure the prevalence and nature of attentional disorders in epileptic patients. Indeed, attentional abilities are often mentioned in studies, but attention is a complex domain defined by four modalities: alertness, selective attention, divided attention and sustained attention. No study systematically assesses all of these modalities.
The objective of this study is to evaluate the prevalence and nature of attentional disorders in epileptic patients compared to control subjects.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prevalence of Cognitive Disorders in Newly Diagnosed Epilepsy
NCT04727931
The Effect of Cognitive Rehabilitation on Epileptic Pateints Under Treatment
NCT06643559
Rehabilitation of Cognition and Psychosocial Well-being in Epilepsy
NCT05934786
Spatial Memory and Temporal Lobe Epilepsy
NCT06847152
The Effect of Mindfulness on Cognition and Emotion Following Acquired Brain Injury
NCT03231488
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
patients with epilepsy
Attentional tasks : D2-R task and TAP battery (sustained attention, alertness, divided attention) executive task : digit span, incompatibility and flexibility task (TAP battery), verbal fluencies depression score (NDDI-E scale) and anxiety score (GAD-7 scale)
Attentional tasks
a neuropsychological assessment of attentional task, executive task and interview is proposed to patients or normal control
Normal controls
Attentional tasks : D2-R task and TAP battery (sustained attention, alertness, divided attention) executive task : digit span, incompatibility and flexibility task (TAP battery), verbal fluencies depression score (NDDI-E scale) and anxiety score (GAD-7 scale)
Attentional tasks
a neuropsychological assessment of attentional task, executive task and interview is proposed to patients or normal control
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Attentional tasks
a neuropsychological assessment of attentional task, executive task and interview is proposed to patients or normal control
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient with written informed consent
* affiliation to a social security regime is compulsory
* Individuals who have received full information about the organization of the research and have not objected to their participation and the use of their data.
* Patient 18 years of age and older
Normal controls:
Individuals who have received full information about the organization of the research and have not objected to their participation and the use of their data.
* People 18 years of age and older
* People with no neurological and/or psychiatric history
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Central Hospital, Nancy, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Brissart H, Forthoffer N, Maillard L. Attention disorders in adults with epilepsy. Determinants and therapeutic strategies. Rev Neurol (Paris). 2019 Mar;175(3):135-140. doi: 10.1016/j.neurol.2019.01.394. Epub 2019 Feb 28.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019-A02748-49
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.